Controlling transcription in human pluripotent stem cells using CRISPR-effectors.

Methods

Program in Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address:

Published: May 2016

The ability to manipulate transcription in human pluripotent stem cells (hPSCs) is fundamental for the discovery of key genes and mechanisms governing cellular state and differentiation. Recently developed CRISPR-effector systems provide a systematic approach to rapidly test gene function in mammalian cells, including hPSCs. In this review, we discuss recent advances in CRISPR-effector technologies that have been employed to control transcription through gene activation, gene repression, and epigenome engineering. We describe an application of CRISPR-effector mediated transcriptional regulation in hPSCs by targeting a synthetic promoter driving a GFP transgene, demonstrating the ease and effectiveness of CRISPR-effector mediated transcriptional regulation in hPSCs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842159PMC
http://dx.doi.org/10.1016/j.ymeth.2015.10.014DOI Listing

Publication Analysis

Top Keywords

transcription human
8
human pluripotent
8
pluripotent stem
8
stem cells
8
crispr-effector mediated
8
mediated transcriptional
8
transcriptional regulation
8
regulation hpscs
8
controlling transcription
4
cells crispr-effectors
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!